Researchers at the Phoenix Veterans Affairs Health Care System studied more than 700 women, between the ages of 42 and 58, who were at low risk for heart disease. Some received hormone therapy by pill; others used a patch.
Results show that after four years, those receiving two low-dose menopausal hormone therapy regimens each month improved some heart disease risk factors. Imaging also showed that the hormone therapy did not affect the progression of hardening and narrowing of the arteries.
Researchers now hope to turn their sights to the long-term effects.
Complete findings for this study are in the journal "Annals of Internal Medicine."
Copyright 2016 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.